Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Senzime Ord Shs SNZZF

Healthcare Medical Devices
Senzime publ AB is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food... see more

Recent & Breaking News (OTCQX:SNZZF)

Interim Report January - September 2024: Strong Sales Growth Driven by Accelerated Sensor Sales

Accesswire November 6, 2024

New Number of Shares and Votes in Senzime AB (publ)

Accesswire October 31, 2024

Invitation to Presentation of Senzime's Third Quarter 2024 Report

Accesswire October 30, 2024

Senzime Successfully Unveils Next-Generation TetraGraph® Quantitative Train-of-Four Monitor at ANESTHESIOLOGY® 2024; U.S. Shipments Begin Q4 2024

PR Newswire October 28, 2024

Bulletin From Extraordinary General Meeting in Senzime AB (publ)

Accesswire October 23, 2024

Senzime Secures First European Hospital Order for its New Next-Generation TetraGraph System

Accesswire October 23, 2024

New Clinical Study Confirms the Industry Leading Performance Of Senzime's TetraGraph System

Accesswire October 19, 2024

Senzime to launch Next-Generation TetraGraph System at ANESTHESIOLOGY 2024 Conference

Accesswire October 15, 2024

Notice of Extraordinary General Meeting in Senzime AB (publ)

Accesswire September 27, 2024

Senzime Secures New Contract With Leading US Healthcare System

Accesswire September 24, 2024

Senzime Provides Market Update and Outlines High Growth Ambitions

Accesswire August 26, 2024

Interim Report January - June 2024: Strong Sales Growth in US Market

Accesswire August 26, 2024

Invitation to Presentation of Senzime's Second Quarter 2024 Report

Accesswire August 20, 2024

Senzime Expands Contract with Leading US Hospital System

Accesswire July 19, 2024

Senzime Granted New European TetraGraph System Patent

Accesswire June 25, 2024

Senzime Wins Contract with the Most Prestigious and Highest Ranked Children's Hospital in the US

Accesswire June 7, 2024

New Clinical Study Published in Anesthesiology Confirms the Leading Accuracy and Precision of Senzime's TetraGraph System

Accesswire May 21, 2024

Senzime Appoints Former Dräger Medical CEO Wolfgang Reim as New Senior Advisor to The Board

Accesswire May 17, 2024

Communique from Annual General Meeting in Senzime AB (publ)

Accesswire May 16, 2024

Interim Report January-March 2024

Accesswire May 7, 2024